Literature DB >> 8675270

Angiotensin II type 2 receptor mRNA expression in the developing cardiopulmonary system of the rat.

S Shanmugam1, P Corvol, J M Gasc.   

Abstract

Recent studies have shown that angiotensin II has a trophic action on the heart. The presence of two types of angiotensin II receptors, type 1 (AT1) and type 2 (AT2), has been reported in the rat heart. This in situ hybridization study describes the tissue and cell location of AT2 receptor mRNA in the developing rat cardiopulmonary system, from 15 days of gestation to adulthood. Expression of AT1A receptor mRNA was studied in parallel for direct comparison. The aortic arch and pulmonary artery expressed high levels of AT2 receptor mRNA from 15 days of gestation up until 15 days postpartum, whereas expression of this mRNA was observed only just before and after birth in the coronary arteries. AT2 receptor mRNA was not detected in any cardiac muscle of the fetus, neonate, or adult. The annulus of all four heart valves expressed AT2 mRNA from 21 days of gestation until 10 days postpartum, but no labeling was seen in the valve leaflets. The subendocardial atrial tissue showed a high level of AT2 receptor mRNA expression during the early postnatal period, but no expression was observed in the atrial myocytes from fetal stages to adulthood. The bronchi and trachea, but not the lung parenchyma, showed a high level of AT2 receptor mRNA expression starting from 17 days of gestation until 10 days postpartum. AT2 receptor mRNA expression in the cardiopulmonary system is therefore transient, developmentally regulated, and mostly located in vascular structures. By these three characteristics, its expression contrasts with that of AT1A, which is continuously expressed in the cardiac muscle to adulthood. This spatiotemporal pattern of expression of angiotensin II receptor mRNAs during development suggests a possible role for angiotensin II in organogenesis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8675270     DOI: 10.1161/01.hyp.28.1.91

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  17 in total

1.  Local fetal lung renin-angiotensin system as a target to treat congenital diaphragmatic hernia.

Authors:  Cristina Nogueira-Silva; Emanuel Carvalho-Dias; Paulina Piairo; Susana Nunes; Maria J Baptista; Rute S Moura; Jorge Correia-Pinto
Journal:  Mol Med       Date:  2012-03-27       Impact factor: 6.354

2.  Plasma angiotensin II concentrations in the early neonatal period.

Authors:  M Miyawaki; T Okutani; R Higuchi; N Yoshikawa
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2006-04-04       Impact factor: 5.747

3.  Ontogeny of angiotensin type 2 and type 1 receptor expression in mice.

Authors:  Juan Gao; Jie Chao; Karma-Jaya K Parbhu; Li Yu; Liang Xiao; Fei Gao; Lie Gao
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2012-04-22       Impact factor: 1.636

4.  Developmental changes in AT1 and AT2 receptor-protein expression in rats.

Authors:  Li Yu; Mingqi Zheng; Wei Wang; George J Rozanski; Irving H Zucker; Lie Gao
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2010-08-31       Impact factor: 1.636

5.  Expression of the AT2 receptor developmentally programs extracellular signal-regulated kinase activity and influences fetal vascular growth.

Authors:  M Akishita; M Ito; J Y Lehtonen; L Daviet; V J Dzau; M Horiuchi
Journal:  J Clin Invest       Date:  1999-01       Impact factor: 14.808

6.  Increased angiotensin II AT1 receptor mRNA and binding in spleen and lung of AT2 receptor gene disrupted mice.

Authors:  Jaroslav Pavel; José A Terrón; Julius Benicky; Alicia Falcón-Neri; Amita Rachakonda; Tadashi Inagami; Juan M Saavedra
Journal:  Regul Pept       Date:  2009-09-17

7.  Specific single chain variable fragment (ScFv) antibodies to angiotensin II AT(2) receptor: evaluation of the angiotensin II receptor expression in normal and tumor-bearing mouse lung.

Authors:  Masaaki Tamura; Heping Yan; Ofelia Zegarra-Moro; Jennifer Edl; Stephanie Oursler; Cindy Chard-Bergstrom; Gordon Andrews; Tsutomu Kanehira; Susumu Takekoshi; Ray Mernaugh
Journal:  J Mol Histol       Date:  2008-04-28       Impact factor: 2.611

8.  Reduced severity of a mouse colitis model with angiotensin converting enzyme inhibition.

Authors:  Ariel U Spencer; Hua Yang; Emir Q Haxhija; Barbara E Wildhaber; Joel K Greenson; Daniel H Teitelbaum
Journal:  Dig Dis Sci       Date:  2007-03-07       Impact factor: 3.199

9.  Impact of AT2 receptor deficiency on postnatal cardiovascular development.

Authors:  Daniel Biermann; Andreas Heilmann; Michael Didié; Saskia Schlossarek; Azadeh Wahab; Michael Grimm; Maria Römer; Hermann Reichenspurner; Karim R Sultan; Anna Steenpass; Süleyman Ergün; Sonia Donzelli; Lucie Carrier; Heimo Ehmke; Wolfram H Zimmermann; Lutz Hein; Rainer H Böger; Ralf A Benndorf
Journal:  PLoS One       Date:  2012-10-29       Impact factor: 3.240

10.  Endothelin A receptor blockade influences apoptosis and cellular proliferation in the developing rat kidney.

Authors:  Kee Hwan Yoo; Hyung Eun Yim; Gi Young Jang; In Sun Bae; Byung Min Choi; Young Sook Hong; Joo Won Lee
Journal:  J Korean Med Sci       Date:  2009-02-28       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.